Migraine headache

ID 84423051 © Kurhan | Dreamstime.com

FDA Approves New Drug to Manage Migraines

May 22, 2018 - 8:48 am

ST. LOUIS (KMOX) - The FDA has approved a new drug that offers hope to millions of people suffering from severe migraines. 

It's called Aimovig, the first in a new class of migraine drugs that aims to both fight and prevent painful migraine headaches before they start.

Dr. Sid Kaul is a neurologist at SSM Health DePaul Hospital who specializes in treating migraines.

“The way it works is that you have to inject it into your body yourself - it’s like auto injector, much like the pens you have for diabetes. You just inject it into your system and it actually gets inside your brain for a period of time and then down-regulates this protein for a period of weeks to months," Kaul says. "It’s taken once a month, and then over a period of time it’s supposed to reduce the number of headaches."

This is the first of several new preventive drugs expected to join the market this year.

Aimovig will cost $6,900 a year, rather than $10,000 or more as some predicted, according to Bloomberg.